Piper Sandler Upgrades Capricor Therapeutics (CAPR) to Overweight 'Ahead of Extended 11/22 PDUFA Date'

September 1, 2026 3:47 AM

(Updated - September 1, 2026 6:31 AM EDT)

Piper Sandler analyst Edward Tenthoff upgraded Capricor Therapeutics (NASDAQ: CAPR) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found